Share Name Share Symbol Market Type Share ISIN Share Description
Totally Plc LSE:TLY London Ordinary Share GB00BYM1JJ00 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.125 -1.05% 11.75 0.00 07:30:05
Bid Price Offer Price High Price Low Price Open Price
11.50 12.00 0.00 0.00 0.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 78.01 -1.82 -2.51 21
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 0.00 GBX

Totally (TLY) Latest News

More Totally News
Totally Takeover Rumours

Totally (TLY) Discussions and Chat

Totally Forums and Chat

Date Time Title Posts
11/12/201920:47Totally Health - 2014 onwards11,429
25/11/201911:03Totally plc 20133,527
14/11/201912:37Feeling Better?540
30/9/201909:13Totally plc - right of reply10
04/1/201913:45Bob Holt OBE, Chairman – Totally (TLY)4

Add a New Thread

Totally (TLY) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-12-11 15:19:2911.8420,7222,452.97O
2019-12-11 14:53:5111.9550,0005,975.00O
2019-12-11 14:53:3611.9550,0005,975.00O
2019-12-11 14:45:1411.9050,0005,950.00O
2019-12-11 14:44:5212.00100,00012,000.00O
View all Totally trades in real-time

Totally (TLY) Top Chat Posts

Totally Daily Update: Totally Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker TLY. The last closing price for Totally was 11.88p.
Totally Plc has a 4 week average price of 11.50p and a 12 week average price of 8.85p.
The 1 year high share price is 16p while the 1 year low share price is currently 8.70p.
There are currently 182,186,111 shares in issue and the average daily traded volume is 179,800 shares. The market capitalisation of Totally Plc is £21,406,868.04.
spacedust: 1gw does know more than directors a d cannacord. Just look at the share price Despite buy rating of 50p the share price ended red. Despite director buy the share price ended red. So yes 1gw knows more based purely on today's share price movement. 1gw let me know when you get back.
sikhthetech: Read the company newsflow: TLY bought Vocare a couple of years ago and transformed the CQC ratings: ""Our CQC ratings have continued to improve, with further progress achieved at Vocare, which now has 19/20 registered services rated as 'Good'. Additionally, About Health, inspected for the first time, received a 'Good' rating with the 'Caring' domain rated as 'Outstanding'. We are extremely proud of these ratings which are testament to the hard work of staff across the whole Group." They are now well positioned to tender for contracts on merit. Awarding contracts on merit is a change taking place within the NHS. They bought GBH, at a decent price, in June, this year and now have a solid foundation. They had been discussing buying GBH for around a year. GBH won a NEW contract recently. They have recently, post H1 period end, announced that they intend to pay an interim dividend - progressive dividend policy, going forward would show they are confident about cash flow. "It is the intention of the Board to declare an interim dividend at the time of the interim results announcement in November 2019." Crucially, they won a NEW contract, which shows that the political situation is NOT effecting the awarding of new contracts. ALL for a mcap of £24m
sikhthetech: Bob bought 274 shares... there's a huge difference between that and the small trades, some around 10k/20k at current prices, which are by the gang manipulating the share price, so to use the TLY share price as 'evidence' not to believe my warnings on trmr... Have a look at the trmr/rthm threads on Lse and advfn... 1gw loves to mention TLY when he's caught out and to distract away from his disasters... Like on Byot today... ;-)
buywell3: TLY share price halved from Sept 1st 2016 to 15th Nov 2017 TLY share price halved again from sept 20th 2017 to 20th sept 2018 TLY share price halved again from sept 20th 2018 to 20th sept 2019 Seems like a pattern to me
grahamwales: Microscope Been here around 3 years now and all I have seen is the share price go down. All I want is for the share price to go up. That’s not too much to ask is it. Bob is playing monopoly with our money trying to build his empire and even himself admitted he doesn’t care what the share price is he will keep spending. By the way Vocare London is still failing having read some notes today. They have spent a small fortune trying to put Vocare right yet still can’t get it to work. Wendy has no idea how to run a profitable business this is not the NHS where she can spend money as and when she wants to try and improve the service Of Vocare. I try and stay positive but when I see the share price continuously drop it’s very difficult. Like I said all I want is to see the share price rise and for the BOD to stop the BS about rewarding investors and get in and do something.
nobbygnome: Well here goes. I am going to post my report although muppets like 1gw do not deserve any help with their (alleged) investment. This was probably the best company meeting I have ever been to. I was the only investor present and consequently got lots of time to ask questions and speak one to one with directors. Bob Holt was not present but all the other directors were. I am going to do this bullet point style. They were talking to Greenbrook since before the Vocare acquisition. However, it made sense to do Vocare first to get the national presence and then they could add on the London coverage of Greenbrook Wendy insisted that they did not overpay for Vocare. It maybe has taken a bit longer to sort out then they thought but it is now a profitable company. There will be cost savings during the integration due to shared functions. The enlarged group will be able to bid for more contracts than before. For example Greenbrook currently only takes on 2 new contracts a year due to logistical issues. However, now that Greenbrook have the TLY logistics they can take on more new contracts annually. There is not and never has been any cash flow issue on the balance sheet; this has been severely misrepresented by certain people. Yes there are big monthly movements in cash up and down (£3 million or so) which is why they need a big cash balance. The NHS is a very good and predictable payer which facilitates the cash flow. I spoke for a while with Michael Steel from Greenbrook. He is absolutely committed to the new business and sees the takeover as the way to rapidly grow both his business and the wider group. He is there for the long term and is very excited about the opportunities which have opened up. He has been looking to sell the business for a while to accelerate growth and patiently waited for TLY understanding the long term issues. There are multiple cross selling opportunities between the different subsidiaries. In addition, CCGs are often now approaching both Vocare and Greenbrook with contracts rather the other way round. There are very few companies which can actually bid for most of them. Probably the most interesting discussion was about the share buyback. There has been a Heads of Agreement with Greenbrook for a long time. They were waiting for a recovery in the share price to do the the purchase at a higher level, although they eventually had to bite the bullet. Don't forget they have been speaking to them since before the Vocare acquisition. This long term discussion and other issues meant that they were severely limited as to when they could actually do a buyback. In fact there were only 2 days in the whole period when the Nomad would have let them do it. You have to understand that the Vocare and Greenbrook acquisitions were a long term strategy which has been going on for years. Essentially the new enlarged group is now poised for significant growth and profitability About Health is doing very well in retaining and winning new contracts. However, the relative size means they are not always RNSed. The results will be released soon and will meet consensus from the 3 brokers. Vocare is definitely profitable! The enlarged group including the cost savings will clearly be even more profitable (my comment). Various new and existing IIs took part in the placing. Miton bought back in big (£3 million) because their earlier sale had been more of an accounting issue and the fund manager was not in agreement with the decision. Wendy thought that the vast majority of the shares were in sticky hands who would stay for the long term The money from the open offer was not required for the takeover and was just to placate PIs. So the fact that the full amount was not achieved is completely irrelevant as it just increases their cash buffer. I for one am very pleased that they enabled PIs to take part. I also spoke to the head of Vocare. He was very optimistic about the future and saw the acquisition as creating big opportunities. The geographical fit couldn't be better. The political risk is being minimised by some of the contracts being in collaboration with NHS entities. So the NHS entity wins the contract and TLY are just a partner. All the people I spoke to said the political risks were not as big as everyone think, although of course you mustn't ignore them. There is no way that the NHS could take all the urgent and managed care functions back in house. Wendy said there would be no more acquisitions in the foreseeable future. Overall I couldn't be happier about TLY now. As I have said before this is a ridiculously undervalued company. When I suggested to Wendy that the price could triple and no-one could complain, she said 'and the rest'. The company thinks that they are many fold undervalued. I think this is going to become very clear shortly as the turnover, profits and contract wins grow. I can't over emphasise how positive Michael Steel from Greenbrook was. Onwards and upwards.... Of course this is reported on a best endeavours basis and you should DYOR.
sikhthetech: 1gw, There's this company who specialise in disinfectant cleaners... you may have heard of them... Byotrol (BYOT).. They bought Medimark, nearly a yr ago as follows..: 1) Initial consideration of £2.3m 2) £0.4m Medimark debt 3) £1.15m cash 4) £1.15m from additional shares @ 4.1p 5) £1.8m deferred subject to achieving EBIDTA targets... Total consideration £4.5m for a company making ADJUSTED EBITDA of ONLY £380k on revenues of just £2.7m... using a similar strategy as TLY.. "year ended 31 March 2018, Medimark reported adjusted EBITDA of GBP380k on revenues of GBP2.7m." "Consideration of up to GBP4.5m is payable in respect of the Acquisition, which includes GBP0.4m of debt that Byotrol is assuming.. Initial consideration of GBP2.3m is payable on completion, being GBP1.15m in cash and GBP1.15m from 28,048,780 new ordinary shares ("Ordinary Shares") being issued at 4.1p per share. An additional GBP1.8m of consideration is payable subject to achieving EBITDA targets in FYE 31 March 2019 and FYE March 2020. The deferred consideration is also to be paid half in cash and half in new ordinary shares." The placing price @ 4.1p, the current share price is around 50% lower @ 2.1p. Your ONE post on the acquisition, on the day of acquisition announced: 1gw - 23 Aug 2018 - 13:10:33 - 3152 of 3628 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT Nice surprise on my return from the beach! Good to see them get the results out today in the end and I like the fact that the acquisition shares are priced above 4p. Also I agree it sounds like good news that the Target trial is being extended - although I suppose it could mean the results are borderline and they need more time to decide whether it is going to be viable. Didn't you look at the accounts, liabilities, strategy etc, before loading up... Oh you did... Management seem to be doing the right thing, eh... Management seem to be doing the right things... 1gw - 28 Feb 2019 - 15:04:42 - 3455 of 3628 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT I've bought some more. Takes Byotrol into the top 3 in my portfolio. High risk, but management seem to be doing the right things and sound confident. I think there is potential for the share price to do very well, especially if they can derisk the US by landing some licensing deals now that they've got such a good shop window through the Target trial. DON'T YOU THINK BYOT OVERPAID FOR MEDIAMARK???? OR IS IT OK BECAUSE YOU AND YOUR MATES FOOTBALL AND SHRODER ARE ALSO INVESTED IN IT. BYOT MCAP IS HIGHER THAN TLY.
1gw: Microscope - do you also believe the earth is flat perhaps? The share price closed at 47p on 23rd October 2017, the day before the Vocare acquisition completed. It was suspended on Friday at 11.25p (according to Yahoo! Finance) Who knows what price placing shares will be issued at? 10p, 8p, less? That is messing up in a big way as far as long-term holders are concerned. It depends how many placing shares they issue, but if it is at the sort of scale that savagedstock has suggested then existing shareholders pretty much lock that loss in because of the dilution. On a willing-seller / willing-buyer basis tly is going to be paying fair value for Greenbrook (plus probably a premium equal to a % of expected synergies). So upside in the merged company comes from exceeding that fair value (plus premium) and any recovery in the underlying existing tly business. Existing tly holders suffer from the dilution (if 2 new placing shares for each 1 existing tly share, then existing holders are exposed to only 1/3 of the upside). And the "reverse" is down to the technical AIM definition - in this case presumably it is the fact that the underlying profit of Greenbrook is higher than that of Tly.
1gw: Low risk? What some of our resident rampers were arguing at a share price of around 25p in August 2018 was that Tly was low risk because of the cash on their balance sheet. I was arguing that this was illusory because of the offsetting liabilities on the balance sheet and that if they needed to fix the balance sheet by a further placing they would probably need a good discount on the share price. Fast forward 9 months to today and to me it looks like the last of the cash is likely to disappear buying Greenbrook - on the basis of them having paid around 7 x PBT or 7 x EBITDA up front for PPH and AH, and for Vocare paying up front a bit more than the cash on the Vocare balance sheet. That's assuming the FY19 Greenbrook accounts are similar to the FY18 accounts. So that leaves them having to raise cash to fix the balance sheet and pay any additional amount up front over what is on the Greenbrook balance sheet. Even if they could raise the cash at 10p (and I doubt that) that would represent a 60% loss on the 25p August share price. In what world is that consistent with tly having been a low-risk investment in August? --------------------------------------- sikhthetech - 10 Aug 2018 - 15:35:26 - 4770 of 8791 "Wouldn't you say it was just a little desperate to present Totally's cash balance relative to market cap as somehow indicative of a low risk investment?" me it's low I've explained/asked.. look at last year's placing and their prior fy2016 accounts… ----------------------------------------- Nobbygnome - 10 Aug 2018 - 11:01:42 - 4738 of 8791 …However, I agree that at this level with the level of cash TLY is very low risk.....despite what some say here. It is all about the management here IMHO...
1gw: Stt- away from the conspiracy theories, any thoughts on the share price weakness? Could it be anything to do with the balance sheet and cash consumption, or how the Canaccord note sees it developing? Could it be anything to do with the level of institutional selling since the placing? Could it possibly be partly to do with the failure of the company to follow through on a share buyback despite the share price now being much lower than when they put the authority in place? Could fear of a Corbyn government be a factor? Or do you think it is all because rthm posters are selling tly to distract you from posting over there? ----------------------- sikhthetech - 13 Dec 2018 - 09:12:55 - 10231 of 10391 graham, "Hopefully no one got caught on the spike" Traders, pretending to be holders... Have a look at the small trade on TLY, resulting in share price fall, perfectly timed, so to distract posters from posting here...
Totally share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191212 07:51:55